Adma Biologics Incの推定成長EPS Q/Q
Adma Biologics Incの推定成長EPS Q/Qは何ですか。
Adma Biologics Incの推定成長EPS Q/Qは-33.33%です。
推定成長EPS Q/Qの定義は何ですか。
期待される四半期ごとのEPS成長率は、過去四半期の業績と比較して、次の四半期の企業EPSの推定増加です。
The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
NASDAQのセクタHealth Careにおける推定成長EPS Q/Qの企業と比べるAdma Biologics Inc
Adma Biologics Incは何をしますか。
adma is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of primary immune deficiency disease (pidd) and certain infectious diseases. adma's mission is to develop and commercialize plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases. the target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease, or who may be immune-compromised for medical reasons. adma’s lead product candidate, ri-002, has completed a phase iii clinical trial in patients with pidd and has met the primary endpoint. a bla for ri-002 was accepted by the fda on september 18, 2015. the company has received u.s. patent 9,107,906. for more information, please visit the company's website at www.admabiologics.com.
Adma Biologics Incと類似の推定成長eps q/q
- Sakuma Exportsの推定成長EPS Q/Qは-33.93%です。
- Hamilton Lane Incの推定成長EPS Q/Qは-33.86%です。
- Glenmark Pharmaceuticalsの推定成長EPS Q/Qは-33.78%です。
- Pembina Pipelineの推定成長EPS Q/Qは-33.75%です。
- Hindustan Aeronauticsの推定成長EPS Q/Qは-33.65%です。
- Genescoの推定成長EPS Q/Qは-33.47%です。
- Adma Biologics Incの推定成長EPS Q/Qは-33.33%です。
- Labcorpの推定成長EPS Q/Qは-33.23%です。
- Encore Capitalの推定成長EPS Q/Qは-33.08%です。
- Portola Pharmaceuticalsの推定成長EPS Q/Qは-32.99%です。
- Societe Generale Societe anonymeの推定成長EPS Q/Qは-32.95%です。
- West Pharmaceutical Servicesの推定成長EPS Q/Qは-32.84%です。
- Randolph Bancorp Incの推定成長EPS Q/Qは-32.84%です。